Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Rinat Yerushalmi | Researchclopedia

Back to researchers

Rinat Yerushalmi

Tel Aviv University ORCID

202

Works

9,425

Citations

32

h-index

62

i10-index

Research Topics

Breast Cancer Treatment Studies BRCA gene mutations in cancer Advanced Breast Cancer Therapies

Affiliations

University of Vermont2008–2008

BC Cancer Agency2008–2015

Mount Sinai Hospital2011–2011

Centre National de la Recherche Scientifique2019–2019

Mater Health Services2017–2019

Top Works

Metastatic Behavior of Breast Cancer Subtypes

Hagen F. Kennecke,Rinat Yerushalmi,et al.

20102,252 citations

Cancer Treatment and Pharmacology

HER2/EGFR in Cancer Research

Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation

Jennifer K. Litton,Hope S. Rugo,et al.

20182,086 citations

Ki67 in breast cancer: prognostic and predictive potential

Rinat Yerushalmi,Ryan Woods,et al.

20101,211 citations

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

Karen A. Gelmon,Marc Tischkowitz,et al.

20111,109 citations

Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial

Jennifer K. Litton,Sara A. Hurvitz,et al.

2020377 citations

Breast carcinoma—rare types: review of the literature

Rinat Yerushalmi,Malcolm Hayes,et al.

2009151 citations

Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes

Rinat Yerushalmi,Karen A. Gelmon,et al.

2011138 citations

Quality of life with talazoparib versus physician’s choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial

Johannes Ettl,Ruben G.W. Quek,et al.

2018136 citations

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer

Raz Mutai,Tamar Barkan,et al.

2021134 citations